首页 | 本学科首页   官方微博 | 高级检索  
     

虎杖中白藜芦醇诱导肝癌细胞HepG-2凋亡及其对Bcl-2和Bax蛋白表达的影响
引用本文:顾生玖,李美波,朱开梅. 虎杖中白藜芦醇诱导肝癌细胞HepG-2凋亡及其对Bcl-2和Bax蛋白表达的影响[J]. 中国实验方剂学杂志, 2014, 20(12): 168-172
作者姓名:顾生玖  李美波  朱开梅
作者单位:河南中医学院, 郑州 450008;河南中医学院, 郑州 450008;河南中医学院, 郑州 450008;河南省中医院, 郑州 450003;河南中医学院, 郑州 450008
基金项目:河南省教育厅资助项目(2010A360024);河南省科技攻关项目(112102310314);郑州市科技领军人才资助项目(112102310314)
摘    要:目的:观察爱罗咳喘宁口服液对慢性阻塞性肺疾病(COPD)大鼠模型血浆及支气管肺泡灌洗液(BALF)中白三烯B4(LTB4)、白细胞介素-6(IL-6)及肺组织病理形态的影响。方法:采用脂多糖(LPS)加烟雾诱导COPD大鼠模型,大鼠随机被分为正常组、模型组、爱罗咳喘宁口服液低、中、高剂量组。正常组、模型组灌胃蒸馏水(10 mL·kg-1·d-1),爱罗咳喘宁口服液低、中、高剂量组分别灌胃混悬液(5,10,20 g·kg-1·d-1),连续7 d。酶联免疫法(ELISA)测定各组大鼠血浆和BALF 中LTB4,IL-6的含量。结果:与正常组相比,模型组大鼠血浆和 BALF 中LTB4,IL-6水平均显著高于正常组(均P<0.05),与模型组相比,爱罗咳喘宁口服液低、中、高剂量组LTB4和IL-6含量均显著降低(均P<0.05)。结论:爱罗咳喘宁口服液治疗COPD的作用机制可能与抑制LTB4,IL-6的释放有关。

关 键 词:爱罗咳喘宁口服液  慢性阻塞性肺疾病  白细胞介素-6  白三烯B4
收稿时间:2013-09-21

Apoptosis of HepG-2 Cell Induced by Resveratrol and Its Effects on Expressions of Proteins Bcl-2 and Bax
GU Sheng-jiu,LI Mei-bo and ZHU Kai-mei. Apoptosis of HepG-2 Cell Induced by Resveratrol and Its Effects on Expressions of Proteins Bcl-2 and Bax[J]. China Journal of Experimental Traditional Medical Formulae, 2014, 20(12): 168-172
Authors:GU Sheng-jiu  LI Mei-bo  ZHU Kai-mei
Affiliation:Henan University of Traditional Chinese Medicine(TCM), Zhengzhou 450008, China;Henan University of Traditional Chinese Medicine(TCM), Zhengzhou 450008, China;Henan University of Traditional Chinese Medicine(TCM), Zhengzhou 450008, China;Henan Province Hospital of TCM, Zhengzhou 450003, China;Henan University of Traditional Chinese Medicine(TCM), Zhengzhou 450008, China
Abstract:Objective: To study the effect of Ailuo Kechuanning oral liquid on leukotriene B4(LTB4), interleukin-6 (IL-6)levels and pathological morphology in plasma and bronchial alveolar lavage fluid (BALF) of rats with chronic obstructive pulmonary disease(COPD). Method: Lipopolysaccharide (LPS) combined with smoke was used to establish COPD rat model;the experimental animals were randomly divided into normal control group,model group,Ailuo Kechuanning oral liquid groups (5,10,20 g·kg-1·d-1), enzyme-linked immunosorbent assay(ELISA) was used to determine the change of LTB4, IL-6 levels in rat plasma and BALF in the rats of all groups before and after treatment. Result: The levels of LTB4,IL-6 in plasma and BALF of the model group were significantly higher than those in normal control group;compared with the model group,the levels of LTB4,IL-6 in plasma and BALF of the rats treated with Ailuo Kechuanning oral liquid were significantly decreased. Conclusion: The mechanism of Ailuo Kechuanning oral liquid for treatment of COPD may be related to the inhibition of LTB4, IL-6 release.
Keywords:Ailuo Kechuanning oral liquid  chronic obstructive pulmonary disease  interleukin-6  leukotriene B4
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号